COMMUNIQUÉS West-GlobeNewswire

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert

04/09/2024 - 10:01

PancAlert is a Next-Generation Pancreatic Cancer Detection Test in Mainz Biomed’s Research and Development Pipeline – Promising Results of First Analysis BERKELEY, Calif. and MAINZ, Germany, Sept. 04, 2024 (GLOBE [...]

Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director

04/09/2024 - 09:00

Dr Paulo Fontoura brings 20 years’ experience of working in the pharma industry, with the most recent 16 years focusing on translational medicine and clinical development approaches for one of the world’s largest [...]

PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board

04/09/2024 - 09:00

PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to [...]

Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

04/09/2024 - 09:00

London, UK – 4 th September 2024. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle [...]

Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis

04/09/2024 - 08:00

New Phase II data show vast majority of patients experiencing no relapses or disability progression Fenebrutinib suppressed acute and chronic MRI lesions Fenebrutinib’s safety profile was consistent with previous and [...]

Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board

04/09/2024 - 07:30

Press Release Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Christine Placet is CFO of Theranexus, and was formerly CEO of Horama and Trophos Michele Garufi, former Chairman [...]

Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration

04/09/2024 - 07:30

Communiqué de presse Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration Christine Placet est Directrice Financière chez Theranexus, et a été précédemment Directrice [...]

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

04/09/2024 - 07:00

Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological [...]

Pharming Group to participate in September investor conferences

04/09/2024 - 07:00

Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the U. [...]

Le réseau de partenariat de centres GlobalReady d’Avance Clinical s’étend à grande vitesse et réunit désormais 2 000 centres membres

04/09/2024 - 06:44

WAKE FOREST, Caroline du Nord et ADÉLAÏDE, Australie, 04 sept. 2024 (GLOBE NEWSWIRE) -- Avance Clinical, l’ORC primé et leader sur le marché des biotechnologies, a annoncé ce jour que 2 000 centres cliniques en Amérique [...]

Deenova announces successful implementation of Closed Loop Medication Management system at Marienhospital Gelsenkirchen

04/09/2024 - 06:00

GELSENKIRCHEN, Germany, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Deenova , leading provider of innovative automation solutions for medication management, is proud to announce the successful implementation of its Closed Loop [...]

Deenova annonce le succès de la mise en place d’un système de gestion des médicaments en circuit fermé à l'hôpital Marien de Gelsenkirchen

04/09/2024 - 06:00

GELSENKIRCHEN, Allemagne, 04 sept. 2024 (GLOBE NEWSWIRE) -- Deenova , un fournisseur leader de solutions d'automatisation innovantes pour la gestion des médicaments, est fier d'annoncer la mise en oeuvre réussie de son [...]

MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting

04/09/2024 - 01:00

LA JOLLA, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

04/09/2024 - 00:45

MELBOURNE, Australia, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s IPAX-1 Phase I study has been published in Neuro-Oncology Advances [...]

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

03/09/2024 - 23:06

Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the YORVIPATH® U.S. commercial launch, and general corporate purposes COPENHAGEN, Denmark and NEW YORK, Sept [...]

QIAGEN N.V. announces conversion price of new net share settled convertible bonds

03/09/2024 - 23:05

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. [...]

Ascendis Pharma Reports Second Quarter 2024 Financial Results

03/09/2024 - 23:04

YORVIPATH approved by U.S. Food & Drug Administration (FDA) as the first and only treatment of hypoparathyroidism in adults TransCon CNP (navepegritide) pivotal ApproaCH Trial topline results expected in the coming [...]

Iovance Biotherapeutics to Present at Upcoming Conferences

03/09/2024 - 23:00

SAN CARLOS, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]

ARCPOINT PROVIDES CORPORATE UPDATE ON BENEFITS OF CRESSO TRANSACTION

03/09/2024 - 22:52

Greenville, South Carolina, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to provide the following corporate update and will host a conference call at 4:45pm [...]